Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 SGIP1 POLA1 POLE ERVK-7 ERVK-8 ERVK-11	5.18e-08	38	185	7	GO:0034061
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 SGIP1 ERVK-7 ERVK-8 ERVK-11	1.21e-07	14	185	5	GO:0003964
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	NAPSA ERVK-6 ERVK-7 ERVK-8 ERVK-19 ERVK-25	1.07e-06	37	185	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	NAPSA ERVK-6 ERVK-7 ERVK-8 ERVK-19 ERVK-25	1.26e-06	38	185	6	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-8 ERVK-11	2.24e-06	11	185	4	GO:0004523
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-8 ERVK-11	3.77e-05	21	185	4	GO:0035613
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-8 ERVK-11	3.71e-04	37	185	4	GO:0016891
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 SGIP1 POLA1 POLE ERVK-7 ERVK-8 ERVK-11	5.47e-04	152	185	7	GO:0016779
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PCDHA9 PAMR1 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2 DLL1 RAB44 LRP8 FER1L5 UNC13A CRB2	6.20e-04	749	185	17	GO:0005509
GeneOntologyMolecularFunction	endopeptidase activity	NAPSA ERVK-6 ADAMTS4 PAMR1 ERVK-7 USP5 CLCA1 CLCA2 ERVK-8 PCSK7 ERVK-19 ERVK-25	6.98e-04	430	185	12	GO:0004175
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERVK-6 SGIP1 POLA1 POLE ERVK-7 LIG4 ERVK-8 ERVK-11 DNMT1	7.77e-04	262	185	9	GO:0140097
GeneOntologyMolecularFunction	transcription coregulator activity	BHLHE41 ASXL1 IL31RA TRIM25 TCF20 FLYWCH1 NACA GON4L NCOR2 KMT2D ATF7IP MAMSTR MYOCD RERE	7.78e-04	562	185	14	GO:0003712
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-8 ERVK-11	8.59e-04	46	185	4	GO:0016893
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	MOK ERVK-6 SGIP1 TRIO BMP2K POLA1 POLE SPEG BAZ1B ERVK-7 CCNK TYRO3 ERVK-8 ULK1 ERVK-11 MAP2K1 MAP2K2 MAP4K2 PIGO	1.17e-03	938	185	19	GO:0016772
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2 TENM3	7.49e-07	187	179	11	GO:0007156
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 POLA1 POLE ERVK-7 ERVK-8 ERVK-11	3.56e-06	48	179	6	GO:0000731
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-8 ERVK-11	3.69e-06	13	179	4	GO:0015074
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2 TENM3 CRB2	1.96e-05	313	179	12	GO:0098742
HumanPheno	Long palpebral fissure	FTSJ1 CCNK KMT2D NEUROG1 ANKRD11 MAP2K1 MAP2K2 PIGO	4.05e-06	71	69	8	HP:0000637
Domain	Cadherin_tail	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.90e-08	37	171	7	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.90e-08	37	171	7	IPR031904
Domain	CADHERIN_1	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	8.76e-08	113	171	10	PS00232
Domain	Cadherin	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	8.76e-08	113	171	10	PF00028
Domain	CADHERIN_2	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	9.53e-08	114	171	10	PS50268
Domain	-	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	9.53e-08	114	171	10	2.60.40.60
Domain	CA	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	1.04e-07	115	171	10	SM00112
Domain	Cadherin-like	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	1.12e-07	116	171	10	IPR015919
Domain	Cadherin	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	1.32e-07	118	171	10	IPR002126
Domain	Cadherin_CS	DCHS2 PCDHA9 DSG2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	7.13e-07	109	171	9	IPR020894
Domain	Cadherin_2	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.12e-06	65	171	7	PF08266
Domain	Cadherin_N	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.12e-06	65	171	7	IPR013164
Domain	-	NHLRC1 APMAP NHLRC2 LRP8 TENM3	2.72e-05	39	171	5	2.120.10.30
Domain	6-blade_b-propeller_TolB-like	NHLRC1 APMAP NHLRC2 LRP8 TENM3	6.14e-05	46	171	5	IPR011042
Domain	Znf_PHD	ASXL1 TCF20 BAZ1B DIDO1 KMT2D PHF3	1.89e-04	91	171	6	IPR001965
Domain	NHL	NHLRC1 NHLRC2 TENM3	2.02e-04	13	171	3	PS51125
Domain	ZF_PHD_2	ASXL1 TCF20 BAZ1B DIDO1 KMT2D PHF3	2.39e-04	95	171	6	PS50016
Domain	CLCA_chordata	CLCA1 CLCA2	2.49e-04	3	171	2	IPR004727
Domain	CLCA	CLCA1 CLCA2	2.49e-04	3	171	2	IPR013642
Domain	hSH3	PRAM1 FYB1	2.49e-04	3	171	2	PF14603
Domain	CLCA	CLCA1 CLCA2	2.49e-04	3	171	2	PF08434
Domain	hSH3	PRAM1 FYB1	2.49e-04	3	171	2	IPR029294
Domain	ZF_PHD_1	ASXL1 TCF20 BAZ1B DIDO1 KMT2D PHF3	2.53e-04	96	171	6	PS01359
Domain	DNA_pol_B	POLA1 POLE	4.94e-04	4	171	2	PF00136
Domain	GPCR_chapero_1	ANKRD13A ANKRD13C	4.94e-04	4	171	2	PF11904
Domain	DNA-dir_DNA_pol_B	POLA1 POLE	4.94e-04	4	171	2	IPR006172
Domain	DNA-dir_DNA_pol_B_exonuc	POLA1 POLE	4.94e-04	4	171	2	IPR006133
Domain	DNA-dir_DNA_pol_B_multi_dom	POLA1 POLE	4.94e-04	4	171	2	IPR006134
Domain	DNA_pol_B_exo1	POLA1 POLE	4.94e-04	4	171	2	PF03104
Domain	ANKRD13	ANKRD13A ANKRD13C	4.94e-04	4	171	2	IPR021832
Domain	POLBc	POLA1 POLE	4.94e-04	4	171	2	SM00486
Domain	FN3_dom	IL13RA1 FLNC IL31RA SPEG CRLF2 TYRO3 ATF7IP CNTFR	6.96e-04	209	171	8	IPR003961
Domain	SPOC_C	DIDO1 PHF3	1.22e-03	6	171	2	IPR012921
Domain	SPOC	DIDO1 PHF3	1.22e-03	6	171	2	PF07744
Domain	PHD	TCF20 BAZ1B DIDO1 KMT2D PHF3	1.35e-03	89	171	5	SM00249
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	6.93e-13	15	186	7	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.08e-12	17	186	7	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.38e-12	18	186	7	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.38e-12	18	186	7	10662547
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNC SHROOM3 FOXK2 TRIO POLE SPEG ZBTB4 WDR70 RAP1GAP2 POMGNT1 KDM6B MBD6 ARHGEF11 DLL1 DCTN1 ABCA7 ARHGEF10L C6orf132 NCOR2 KMT2D SCAP GAREM2 NFATC1 ZNF341 ANKRD11 ULK1 EVI5L PPP1R16A	9.17e-12	1105	186	28	35748872
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.58e-11	24	186	7	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.20e-10	28	186	7	15347688
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6	1.87e-09	11	186	5	9655502
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6	3.18e-09	12	186	5	10612399
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	ERVK-6 PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	7.15e-09	75	186	8	15372022
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.36e-08	57	186	7	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.67e-08	58	186	7	30377227
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DOCK1 ASXL1 FLNC PCDHA9 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 ARHGEF11 SHANK3 FYB1 CNTFR	2.95e-08	329	186	13	17474147
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NELFE ZC3H14 UBAP2 TCF20 DSG2 BAZ1B PPP1R13B DIDO1 DCTN1 CCNK NKRF KMT2D PHF3 LPP ZNF598 DNMT1	5.13e-08	549	186	16	38280479
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	8.22e-08	68	186	7	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.23e-07	72	186	7	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.49e-07	74	186	7	10817752
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NELFE ZC3H14 ISYNA1 UBAP2 TRIM25 ACACB DSG2 NACA WDR70 BAZ1B DIDO1 DCTN1 CCNK NKRF ZNF512B PRCC ATF7IP LPP ZNF598 DNMT1	1.64e-07	934	186	20	33916271
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.96e-07	77	186	7	10835267
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NELFE SHROOM3 UBAP2 TCF20 TRIO DSG2 EXPH5 C6orf132 PHF3 PLEKHG3 LPP ANKRD11 RAB11FIP5 CRYBG3 GNAS ZNF598 MAP2K1 MAP2K2 DNMT1	2.16e-07	861	186	19	36931259
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	2.55e-07	80	186	7	10716726
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	FOXK2 TCF20 TRIO POLA1 NACA DIDO1 CCNK PDE12 PRCC PHF3 RAB11FIP5 ASPSCR1 CRYBG3 MAP2K1	2.93e-07	472	186	14	38943005
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2 LPP	1.07e-06	193	186	9	22589738
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-19	1.49e-06	5	186	3	12629516
Pubmed	Human transcription factor protein interaction networks.	ASXL1 FOXK2 UBAP2 TCF20 ACACB NACA ZBTB9 BAZ1B PPP1R13B GON4L DIDO1 MBD6 NKRF ZNF512B NCOR2 KMT2D SALL2 PRCC ATF7IP NOC4L RERE ZMYM3 CPEB1	2.66e-06	1429	186	23	35140242
Pubmed	Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells.	FLNC MAP2K1 MAP2K2	2.97e-06	6	186	3	9006895
Pubmed	Interaction network of human early embryonic transcription factors.	FOXK2 TCF20 ACACB ZBTB9 BAZ1B MBD6 ZNF512B NCOR2 KMT2D RERE ZMYM3	3.36e-06	351	186	11	38297188
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	NELFE ZC3H14 ASXL1 PLBD1 CTTNBP2 TRIM25 CYP11A1 BAZ1B TRIM65 NHLRC2 DCTN1 ANKRD13A ARHGAP22 USP5 ZNF341 MAMSTR CBX7 MAP2K2 CNTFR CRB2 SNX5	3.53e-06	1242	186	21	30973865
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.78e-06	119	186	7	28625976
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNC EXPH5 CYP11A1 PPP1R13B DCTN1 ZNF512B ANKRD13A NCOR2 USP5 KMT2D TENM3 ZNF341 ATF7IP PPP1R37	4.09e-06	591	186	14	15231748
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NELFE ZC3H14 UBAP2 TCF20 ZBTB9 BAZ1B DIDO1 CCNK NKRF TASOR2 ZNF512B PRAM1 NCOR2 PRCC PHF3 ATF7IP ANKRD11 DNMT1	4.16e-06	954	186	18	36373674
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	CTTNBP2 FLYWCH1 DSG2 POLA1 LAMA2 GON4L DIDO1 PRR22 NDUFB9 TASOR2 NCOR2 USP5 SCAP PLEKHG3 DLST ERVK-25 GNAS SLC7A5P1 GMPPA PPP1R16A	9.04e-06	1215	186	20	15146197
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-8 ERVK-19 ERVK-25 ERVK-11	1.19e-05	94	186	6	21542922
Pubmed	Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome.	NFATC1 MAP2K1 MAP2K2	1.23e-05	9	186	3	19017799
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 FLNC TCF20 POLA1 POLE BAZ1B DIDO1 NKRF TASOR2 USP5 PHF3 NOC4L ZMYM3 DNMT1	1.26e-05	653	186	14	22586326
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ASXL1 FLNC FOXK2 FLYWCH1 POLE WDR70 FOXA2 DCTN1 NKRF NCOR2 LIG4 KMT2D SALL2 NFATC1 ZNF598 ZMYM3	1.66e-05	857	186	16	25609649
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TCF20 ACACB ZBTB9 DCTN1 NCOR2 KMT2D SALL2 ATF7IP RERE CRYBG3 ZMYM3	1.73e-05	418	186	11	34709266
Pubmed	Grhl3 and Lmo4 play coordinate roles in epidermal migration.	GRHL3 MAP2K1 MAP2K2	1.76e-05	10	186	3	18619436
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H14 SHROOM3 FOXK2 TRIM25 FLYWCH1 BMP2K DSG2 NACA BAZ1B GON4L DIDO1 ARHGEF11 NDUFB9 CCNK NKRF C6orf132 PHF3 PLEKHG3 ANKRD11 NOC4L ZNF598 ZMYM3	1.84e-05	1497	186	22	31527615
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PCDHA9 DIDO1 KDM6B ARHGEF11 SALL2 ZMYM3	2.12e-05	104	186	6	9205841
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	ZC3H14 FOXK2 TRIM25 ZBTB9 DIDO1 ECM1 CCNK PHF3 GMPPA	2.24e-05	281	186	9	24163370
Pubmed	VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway.	CLCA1 MAP2K1 MAP2K2	2.41e-05	11	186	3	34010630
Pubmed	Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.	MAP2K1 MAP2K2	2.84e-05	2	186	2	9563949
Pubmed	Mek2 is dispensable for mouse growth and development.	MAP2K1 MAP2K2	2.84e-05	2	186	2	12832465
Pubmed	Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.	BRINP1 DNMT1	2.84e-05	2	186	2	28427182
Pubmed	Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.	FLNC TRIO	2.84e-05	2	186	2	16914736
Pubmed	Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19014680
Pubmed	Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.	MAP2K1 MAP2K2	2.84e-05	2	186	2	26625317
Pubmed	Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.	RAB44 NFATC1	2.84e-05	2	186	2	28791425
Pubmed	Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation.	MAP2K1 MAP2K2	2.84e-05	2	186	2	21699731
Pubmed	Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.	MAP2K1 MAP2K2	2.84e-05	2	186	2	17419998
Pubmed	MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response.	MAP2K1 MAP2K2	2.84e-05	2	186	2	23735655
Pubmed	Phase separation and zinc-induced transition modulate synaptic distribution and association of autism-linked CTTNBP2 and SHANK3.	CTTNBP2 SHANK3	2.84e-05	2	186	2	35562389
Pubmed	The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma.	MAP2K1 MAP2K2	2.84e-05	2	186	2	35069558
Pubmed	The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.	MAP2K1 MAP2K2	2.84e-05	2	186	2	21527500
Pubmed	Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19383924
Pubmed	MEK1 and MEK2, different regulators of the G1/S transition.	MAP2K1 MAP2K2	2.84e-05	2	186	2	15284233
Pubmed	Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19156172
Pubmed	p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2.	MAP2K1 MAP2K2	2.84e-05	2	186	2	12839928
Pubmed	MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo.	MAP2K1 MAP2K2	2.84e-05	2	186	2	16957420
Pubmed	T cell adhesion primes antigen receptor-induced calcium responses through a transient rise in adenosine 3',5'-cyclic monophosphate.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19144315
Pubmed	Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19500021
Pubmed	Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.	MAP2K1 MAP2K2	2.84e-05	2	186	2	22197931
Pubmed	Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas.	MAP2K1 MAP2K2	2.84e-05	2	186	2	27956260
Pubmed	Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.	MAP2K1 MAP2K2	2.84e-05	2	186	2	17981815
Pubmed	The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.	NACA GNAS	2.84e-05	2	186	2	24550008
Pubmed	Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells.	MAP2K1 MAP2K2	2.84e-05	2	186	2	28746311
Pubmed	Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases.	MAP2K1 MAP2K2	2.84e-05	2	186	2	30087384
Pubmed	Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity.	MAP2K1 MAP2K2	2.84e-05	2	186	2	22833572
Pubmed	ERK1/2 can feedback-regulate cellular MEK1/2 levels.	MAP2K1 MAP2K2	2.84e-05	2	186	2	26163823
Pubmed	Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1.	KDM6B NFATC1	2.84e-05	2	186	2	21735477
Pubmed	Omics profiling identifies the regulatory functions of the MAPK/ERK pathway in nephron progenitor metabolism.	MAP2K1 MAP2K2	2.84e-05	2	186	2	36189831
Pubmed	Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.	MAP2K1 MAP2K2	2.84e-05	2	186	2	22805292
Pubmed	Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.	MAP2K1 MAP2K2	2.84e-05	2	186	2	22805291
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	2.84e-05	2	186	2	9060628
Pubmed	Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway.	MAP2K1 MAP2K2	2.84e-05	2	186	2	35975983
Pubmed	Inhibitors of the mitogen-activated protein kinase kinase 1/2 signaling pathway clear prion-infected cells from PrPSc.	MAP2K1 MAP2K2	2.84e-05	2	186	2	16162927
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	2.84e-05	2	186	2	9460924
Pubmed	Regulation of intracellular MEK1/2 translocation in mouse oocytes: cytoplasmic dynein/dynactin-mediated poleward transport and cyclin B degradation-dependent release from spindle poles.	MAP2K1 MAP2K2	2.84e-05	2	186	2	17507801
Pubmed	Intron-less processed Pcdhalpha genes in the central nervous system.	PCDHA8 PCDHA6	2.84e-05	2	186	2	14697259
Pubmed	Activation of two isoforms of mitogen-activated protein kinase kinase in response to epidermal growth factor and nerve growth factor.	MAP2K1 MAP2K2	2.84e-05	2	186	2	8529659
Pubmed	Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product.	MAP2K1 MAP2K2	2.84e-05	2	186	2	1381507
Pubmed	[Mek1 and Mek2 functions in the formation of the blood placental barrier].	MAP2K1 MAP2K2	2.84e-05	2	186	2	22549869
Pubmed	The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.	MAP2K1 MAP2K2	2.84e-05	2	186	2	23480967
Pubmed	Identification and characterization of a novel chemotype MEK inhibitor able to alter the phosphorylation state of MEK1/2.	MAP2K1 MAP2K2	2.84e-05	2	186	2	23237773
Pubmed	Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.	NCOR2 MAP2K1	2.84e-05	2	186	2	23225884
Pubmed	Cisplatin inhibits MEK1/2.	MAP2K1 MAP2K2	2.84e-05	2	186	2	26155939
Pubmed	Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin.	MAP2K1 MAP2K2	2.84e-05	2	186	2	19198628
Pubmed	Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.	MAP2K1 MAP2K2	2.84e-05	2	186	2	15979847
Pubmed	ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro.	MAP2K1 MAP2K2	2.84e-05	2	186	2	25491074
Pubmed	Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2.	MAP2K1 MAP2K2	2.84e-05	2	186	2	20172001
Pubmed	Chromosome mapping of the human genes encoding the MAP kinase kinase MEK1 (MAP2K1) to 15q21 and MEK2 (MAP2K2) to 7q32.	MAP2K1 MAP2K2	2.84e-05	2	186	2	10828601
Pubmed	Lipid-binding hSH3 domains in immune cell adapter proteins.	PRAM1 FYB1	2.84e-05	2	186	2	16831444
Pubmed	Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.	ASXL1 KDM6B	2.84e-05	2	186	2	37917239
Pubmed	Exome-wide association study of replicable nonsynonymous variants conferring risk for alcohol dependence.	UBAP2 LRP8	2.84e-05	2	186	2	23739027
Pubmed	Implication of MEK1 and MEK2 in the establishment of the blood-placenta barrier during placentogenesis in mouse.	MAP2K1 MAP2K2	2.84e-05	2	186	2	22561024
Pubmed	Self-cleavage of human CLCA1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activation.	CLCA1 CLCA2	2.84e-05	2	186	2	23112050
Pubmed	Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.	MAP2K1 MAP2K2	2.84e-05	2	186	2	15543157
Pubmed	Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.	MAP2K1 MAP2K2	2.84e-05	2	186	2	18390968
Pubmed	Combinatorial signalling controls Neurogenin2 expression at the onset of spinal neurogenesis.	FOXA2 DLL1 NEUROG1	3.20e-05	12	186	3	18590718
Interaction	PCDHA3 interactions	PCDHA9 GHDC PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.70e-08	34	179	7	int:PCDHA3
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3	2.99e-08	22	179	6	int:PCDHA10
Interaction	TERF2IP interactions	NELFE ZC3H14 FOXK2 TCF20 POLA1 WDR70 DIDO1 ZNF414 TASOR2 ZNF512B NCOR2 SALL2 PRCC PHF3 ATF7IP ANKRD11 HAAO ZMYM3 DNMT1	5.07e-07	552	179	19	int:TERF2IP
Interaction	TOP3B interactions	FLNC SHROOM3 FOXK2 UBAP2 TRIM25 TRIO POLE SPEG ZBTB4 WDR70 RAP1GAP2 POMGNT1 KDM6B MBD6 ARHGEF11 DLL1 DCTN1 ABCA7 ARHGEF10L C6orf132 NCOR2 KMT2D SCAP GAREM2 NFATC1 ZNF341 ANKRD11 DLST ULK1 GNAS ZNF598 EVI5L PPP1R16A	6.72e-07	1470	179	33	int:TOP3B
Interaction	PCDHA1 interactions	PCDHA11 PCDHA8 PCDHA3 PCDHA1	7.32e-07	9	179	4	int:PCDHA1
Interaction	PPIA interactions	NELFE ASXL1 FLNC FOXK2 TRIM25 TCF20 TRIO POLA1 NACA DIDO1 MBD6 CCNK SHANK3 LIG4 PDE12 PRCC PHF3 RAB11FIP5 DLST ASPSCR1 CRYBG3 ZNF598 MAP2K1	4.14e-06	888	179	23	int:PPIA
Interaction	ZYX interactions	SECISBP2L SHROOM3 FOXK2 TRIM25 BMP2K DSG2 NHLRC2 ZNF512B LPP CRYBG3 ZNF598 GMPPA SNX5	8.11e-06	329	179	13	int:ZYX
Interaction	LONP2 interactions	PCDHA9 TRIM25 PCDHA11 PCDHA8 PCDHA3 ARHGEF11	1.84e-05	62	179	6	int:LONP2
Interaction	PCDHA11 interactions	PCDHA9 PCDHA11 PCDHA3 PCDHA1	2.10e-05	19	179	4	int:PCDHA11
Interaction	PCDHA6 interactions	PCDHA8 PCDHA6 PCDHA3	5.56e-05	9	179	3	int:PCDHA6
Cytoband	5q31	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	4.85e-07	115	186	7	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 NEUROG1 FCHSD1	4.01e-06	298	186	9	chr5q31
Cytoband	20p11	FOXA2 SNX5	1.62e-04	5	186	2	20p11
Cytoband	12q24.3	POLE ULK1	2.42e-04	6	186	2	12q24.3
Cytoband	22q13.3	TCF20 SHANK3	2.42e-04	6	186	2	22q13.3
Cytoband	12q24.11	ACACB ANKRD13A CCDC63	3.26e-04	33	186	3	12q24.11
GeneFamily	Clustered protocadherins	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.82e-07	64	117	7	20
GeneFamily	Chloride channel accessory	CLCA1 CLCA2	2.47e-04	4	117	2	867
GeneFamily	Mitogen-activated protein kinase kinases	MAP2K1 MAP2K2	8.54e-04	7	117	2	653
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF11 ARHGEF10L PLEKHG3	8.81e-04	66	117	4	722
GeneFamily	Ankyrin repeat domain containing	CTTNBP2 PPP1R13B SHANK3 ANKRD13A ANKRD13C ANKRD11 PPP1R16A	1.00e-03	242	117	7	403
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL13RA1 IL31RA IL17RA	2.52e-03	42	117	3	602
GeneFamily	PHD finger proteins	BAZ1B DIDO1 KMT2D PHF3	2.77e-03	90	117	4	88
GeneFamily	Fibronectin type III domain containing	IL31RA CRLF2 TYRO3 ATF7IP CNTFR	3.86e-03	160	117	5	555
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GON4L NCOR2 RERE	4.89e-03	53	117	3	532
GeneFamily	Cadherin related	DCHS2 CLSTN2	5.30e-03	17	117	2	24
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	MOK IL13RA1 FLNC COL8A1 PAMR1 DSG2 SPEG ZNF524 ZNF512B TYRO3 ARHGAP22 PLAAT3 NCOR2 RSPH3 SCAP MAMSTR FUCA1 ZMYM3 CRB2 PPP1R16A	9.95e-06	955	180	20	M45680
Coexpression	GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN	IL13RA1 BMP2K DSG2 GON4L C11orf16 NEUROG1 CLCN1 LPP RAB11FIP5	1.06e-05	200	180	9	M9084
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	PCDHA9 SPEG TRPC3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 TNFSF13B	1.40e-05	261	180	10	MM1277
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	COL8A1 CTTNBP2 TRIO BAZ1B PCDHA11 CLCA1 CLCA2 MYOCD GRHL3	1.05e-05	170	172	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	DSG2 GLB1L TRIM65 PRR22 NHLRC2 ARHGAP22 ZNF469 TENM3 ANKRD13C	1.37e-07	200	181	9	fe772d98c461c973dfc082e1fc50117c27ced804
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L PLEKHG3 IL17RA FYB1	2.83e-07	158	181	8	121d63b8e2e37107467b170e5b2c798a7dbf6325
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 SGIP1 ADAMTS4 PAMR1 LAMA2 CLSTN2 MYOCD LGR6	7.94e-07	181	181	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA1 PLBD1 DSG2 ACOT9 EXPH5 DLL1 CLCA2 LGR6	1.01e-06	187	181	8	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC ISYNA1 ADAMTS4 SPEG CLSTN2 PDE12 IGHG2 MYOCD	1.50e-06	197	181	8	3332b9b5bf78f0203ebbd94257a36e9054d896c3
ToppCell	control-unassigned\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF20 ACACB POLE PPP1R13B LRP8 ZNF341 LGR6 CCDC180	1.62e-06	199	181	8	5db7c8089172ac8e796613b3cef618d87007a0ab
ToppCell	LPS-IL1RA-Endothelial-Mes-Like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NHLRC1 TIMM17B FLNC MYOCD PRRX2 DNMT1 PPP1R16A	1.91e-06	142	181	7	c3a5a80f78704d34db5df85d6e3e8fc84ff24268
ToppCell	droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	3.14e-06	153	181	7	6dcab3d50ab50051955204dc4e4a64c1ca855bcd
ToppCell	droplet-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	3.14e-06	153	181	7	f6ef14d949107c08cb3690e26ec91e194cb43518
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.22e-06	160	181	7	bc4a93dc5f37829799c37877e751ff3bc122e4ab
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.22e-06	160	181	7	2020b6defbaf5b5db12af37f0103ac028a8ca76e
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.22e-06	160	181	7	af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae
ToppCell	facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.58e-06	162	181	7	3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704
ToppCell	facs-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.58e-06	162	181	7	8134f73eb76693f4f1845f643042fdc1e81c274c
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.77e-06	163	181	7	bbbc3f0ce2616d07136f69ce682ba1d3790711d9
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	C11orf16 PLAAT3 CLCA2 GNAS CCDC180 MAP4K2 UNC13A	4.77e-06	163	181	7	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	C11orf16 PLAAT3 CLCA2 GNAS CCDC180 MAP4K2 UNC13A	4.77e-06	163	181	7	5d49414432db259a19df50d7944581d00b69f537
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	4.96e-06	164	181	7	11dfd84f5fb90de330858e1e852848832734e004
ToppCell	facs-Lung-nan-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 TRIM25 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.16e-06	165	181	7	720649f330382ea2a68c64a5344160a048afb8f1
ToppCell	COVID-19-APC-like-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	BHLHE41 ZC3H14 TGIF2 ZNF341 IGHG2 FUCA1 GMPPA	5.59e-06	167	181	7	854a5dbd43f2b25825a71d37fd7779507783a99a
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	6.04e-06	169	181	7	411556e93adcbb7e4d79b02f3dc72963ec8a0759
ToppCell	droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 IL31RA RAP1GAP2 ARHGEF10L IL17RA FYB1	6.04e-06	169	181	7	39b1acfd099abb9de18c29c05c7a67709ea76775
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	ACACB PAMR1 CYP11A1 GLB1L PRAM1 LGR6 CRB2	6.53e-06	171	181	7	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A1 SHROOM3 SGIP1 SPEG TRPC3 LAMA2 CLSTN2	9.13e-06	180	181	7	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A1 SHROOM3 SGIP1 SPEG TRPC3 LAMA2 CLSTN2	9.13e-06	180	181	7	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	E18.5-samps-Mesenchymal-Pericyte\|E18.5-samps / Age Group, Lineage, Cell class and subclass	IL13RA1 HIC1 SGIP1 TRPC3 LAMA2 ECM1 GNAS	9.13e-06	180	181	7	0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	TCF20 KCTD13 BAZ1B ZNF512B TBCCD1 ZNF341 EVI5L	9.46e-06	181	181	7	b193f3606554adc55c5906219d114288bb1f978a
ToppCell	facs-Skin-Telogen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA1 PLBD1 CTTNBP2 ACOT9 EXPH5 CLCA2 GRHL3	1.02e-05	183	181	7	26b18d1cc5d98f185176e100bafb9bc9081c66f7
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTTNBP2 PCDHA13 PCDHA3 CLSTN2 ATF7IP RERE CRYBG3	1.21e-05	188	181	7	e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 DSG2 EXPH5 KDM6B DLL1 ARHGAP22 CLCA2	1.25e-05	189	181	7	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	PCDHA9 GLB1L FAM220A RAP1GAP2 CLSTN2 NFATC1	1.35e-05	127	181	6	9071cd0953c8bb6746dc9cd13d153e3d6ef40b08
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS4 TRIO KDM6B C6orf132 TENM3 NFATC1 LPP	1.39e-05	192	181	7	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL13RA1 SPEG TENM3 CLCA2 PLEKHG3 MYOCD GRHL3	1.43e-05	193	181	7	469a7f1c2ff7137cc5a064464456911f67f92e70
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ISYNA1 SGIP1 ADAMTS4 TRPC3 LAMA2 PCDHA3 ECM1	1.48e-05	194	181	7	8f19e553f18c313c2a2ff9453884b9484b255d71
ToppCell	P28-Mesenchymal-myocytic_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL8A1 SPEG ECM1 LPP MYOCD LGR6 CNTFR	1.48e-05	194	181	7	83e45441c74b7f50b6725876b583229280179dc2
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ISYNA1 SGIP1 ADAMTS4 TRPC3 LAMA2 PCDHA3 ECM1	1.48e-05	194	181	7	67fbb81b7d20cb63be27b2a2beea5b5689f8e08c
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL8A1 SPEG CLCA2 PLEKHG3 LPP MYOCD GRHL3	1.53e-05	195	181	7	43d372373367b71243c6ea958aedccde4478618f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL8A1 HIC1 PAMR1 LAMA2 ECM1 ZNF469 TENM3	1.59e-05	196	181	7	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BHLHE41 DCHS2 COL8A1 CTTNBP2 CLSTN2 TENM3 CRB2	1.75e-05	199	181	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BHLHE41 DCHS2 COL8A1 CTTNBP2 CLSTN2 TENM3 CRB2	1.75e-05	199	181	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POMGNT1 FTSJ1 C11orf16 RAB44 PRAM1 MAP4K2	1.75e-05	133	181	6	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POMGNT1 FTSJ1 C11orf16 RAB44 PRAM1 MAP4K2	1.75e-05	133	181	6	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	COVID-mono1\|COVID / Condition, Cell_class and T cell subcluster	BHLHE41 IL13RA1 PLBD1 CTTNBP2 BMP2K ARHGEF10L ARHGAP22	1.81e-05	200	181	7	bd002c54305c746c07b7418a2084195e9c852ec5
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC SGIP1 ADAMTS4 SPEG CLSTN2 MYOCD PRRX2	1.81e-05	200	181	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	COVID-mono1-\|COVID / Condition, Cell_class and T cell subcluster	BHLHE41 IL13RA1 PLBD1 CTTNBP2 BMP2K ARHGEF10L ARHGAP22	1.81e-05	200	181	7	445a1aab962673dcc926c33ce9bed5ede9c41c57
ToppCell	distal-1-mesenchymal-Adventitial_Fibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS4 PAMR1 LAMA2 ECM1 ANGPTL7 CNTFR PRRX2	1.81e-05	200	181	7	738060ed65fa5473fdb39e686f7cdecc059ed92c
ToppCell	COVID\|World / Condition, Cell_class and T cell subcluster	BHLHE41 IL13RA1 PLBD1 BMP2K ARHGEF10L ARHGAP22 GNAS	1.81e-05	200	181	7	04a932fe2431e7886120c219ce666f90d3030a1c
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRC38 SPEG CLCN1 PLEKHG3 MAMSTR CNTFR	2.75e-05	144	181	6	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACACB PAMR1 LAMA2 LRP8 MMUT CNTFR	2.85e-05	145	181	6	e808502fa52baf1c400f3c9b918a167127e78af9
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MOK HIC1 CTTNBP2 RAP1GAP2 DCTN1 ZNF512B	3.33e-05	149	181	6	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MOK HIC1 CTTNBP2 RAP1GAP2 DCTN1 ZNF512B	3.45e-05	150	181	6	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	4.30e-05	156	181	6	166f7b1220eaf8e1149dde260dd85a094855c54f
ToppCell	PND07-28-samps-Myeloid-Granulocyte\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	4.30e-05	156	181	6	5e1c5a7c9293b886920739cf766521df7f69726c
ToppCell	droplet-Fat-Scat-21m-Hematologic\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 FAM220A PCDHA8 CLCA2 BTN1A1	4.76e-05	97	181	5	440d45ecfc9b66cb61d734118601e745892d51e3
ToppCell	droplet-Fat-Scat-21m-Hematologic-erythroblast\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 FAM220A PCDHA8 CLCA2 BTN1A1	4.76e-05	97	181	5	6fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6
ToppCell	facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.31e-05	162	181	6	484ea4ac40de672dcbd2583a52cb7f385c918814
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.31e-05	162	181	6	bba144ac5332bab9eba2ccf599703c781a7f88f1
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC CLCA1 CLCA2 NFATC1 RAB11FIP5 GNAS	5.31e-05	162	181	6	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.49e-05	163	181	6	f6c8db5963ee1f8e0c2996f1aeecd58c00e9b099
ToppCell	P07-Endothelial-lymphatic_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLAAT3 CLCA2 RAB11FIP5 IL17RA GNAS MAP4K2	5.49e-05	163	181	6	5cbab3d03bb1af9391ecad635d6eea1dd42c1337
ToppCell	P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLAAT3 CLCA2 RAB11FIP5 IL17RA GNAS MAP4K2	5.49e-05	163	181	6	322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.68e-05	164	181	6	cd0794f84dfd346807e2d803723718b7f22e9232
ToppCell	droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.68e-05	164	181	6	ea2897942ad72fba900c7ab354d6a9e203bf0e4a
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	5.68e-05	164	181	6	12251a49fd4af32d4edb58046245548c260cf04b
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CTTNBP2 SPEG LINC02875 MYOCD LGR6 CDRT15P3	5.68e-05	164	181	6	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial-AT1\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	UBAP2 EXPH5 PPP1R13B C6orf132 GRHL3 CRB2	5.88e-05	165	181	6	b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP8 CLCA1 CLCN1 CLCA2 PKHD1 GRHL3	5.88e-05	165	181	6	936581de8fcd097401707438b9bbe89dd4e3e247
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 KDM6B RAB44 PRAM1 IL17RA CCDC63	5.88e-05	165	181	6	4fe7c3c9370a556cf4e308a2e723b4b907a6cc25
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 EXPH5 PPP1R13B FOXA2 ARHGAP22 CPEB1	6.08e-05	166	181	6	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	droplet-Lung-LUNG-1m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.08e-05	166	181	6	dd5944101ef58a9a29aa3eb5c17690119572b8f1
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.08e-05	166	181	6	8e5e8de51b4dacdadaa5a08279df30b5c7ed3628
ToppCell	LV-11._Adipocyte\|World / Chamber and Cluster_Paper	ACACB APMAP TYRO3 PLAAT3 TENM3 PLIN1	6.08e-05	166	181	6	7e5852891714465c6228c9f955fd511ec79d0e02
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 EXPH5 PPP1R13B FOXA2 ARHGAP22 CPEB1	6.08e-05	166	181	6	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL8A1 SHROOM3 NKRF CLCA2 NOC4L DNMT1	6.28e-05	167	181	6	29d271643f3a1718b53db77b7d093ec94225a824
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL8A1 PAMR1 EXPH5 PCDHA3 MAMSTR LGR6	6.71e-05	169	181	6	1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.71e-05	169	181	6	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.71e-05	169	181	6	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL8A1 PAMR1 EXPH5 PCDHA3 MAMSTR LGR6	6.71e-05	169	181	6	58098f8801ca941aeddafb47e88ab0df8b9edb57
ToppCell	droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.71e-05	169	181	6	b059304543876f514d5c7214f1f0a2da00f10a67
ToppCell	droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.71e-05	169	181	6	945f737984c4de70a4e9c214053b005358053dd5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 BRINP1 CLSTN2 ARHGEF10L PLEKHG3 PKHD1	6.93e-05	170	181	6	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	6.93e-05	170	181	6	4d28dc9eb572f43809619f923978cd7494853d43
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	7.16e-05	171	181	6	ed5886d6aa87b2d73469d39dc217227bd4d4c918
ToppCell	droplet-Lung-nan-21m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	7.39e-05	172	181	6	51bea97564a33f0060c546c9be4bf8bf8f1660f6
ToppCell	facs-Liver-Non-hepatocytes-24m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 CRLF2 IL17RA FYB1	7.39e-05	172	181	6	66823536288c7009ce01b5177794a3e874e94570
ToppCell	droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PLBD1 RAP1GAP2 ARHGEF10L IL17RA FYB1	7.39e-05	172	181	6	be4dd4ba8d7a651677c797c25fd75f14e627415a
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DCHS2 POLA1 POLE TBC1D7 TASOR2 DNMT1	7.39e-05	172	181	6	7c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CTTNBP2 SGIP1 EXPH5 TYRO3 TENM3 CRB2	8.13e-05	175	181	6	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXK2 TRPC3 DLL1 SALL2 RAB11FIP5 NOC4L	8.66e-05	177	181	6	8dfadd9852e0c256363471a7cfe6af120c8c51e0
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXK2 TRPC3 DLL1 SALL2 RAB11FIP5 NOC4L	8.66e-05	177	181	6	767b2af5f224d100b22bed32f86cec1cd17e8711
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL8A1 PAMR1 LAMA2 PLIN1 CNTFR PRRX2	8.66e-05	177	181	6	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 DSG2 C11orf16 C6orf132 TYRO3 PKHD1	8.66e-05	177	181	6	7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CTTNBP2 SPEG LINC02875 LAMA2 MYOCD LGR6	8.66e-05	177	181	6	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXK2 TRPC3 DLL1 SALL2 RAB11FIP5 NOC4L	8.66e-05	177	181	6	5ef2527e9b41e62f1724cdabaad9d8979266bb7d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 EXPH5 CLSTN2 TYRO3 TENM3 MAP2K1	8.66e-05	177	181	6	f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCell	E18.5-Endothelial-Endothelial_lymphatic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXK2 TRPC3 DLL1 SALL2 RAB11FIP5 NOC4L	8.66e-05	177	181	6	ae1d2fdd4f67f50c906b27ea084de058c6908aa2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL8A1 PAMR1 LAMA2 PLIN1 CNTFR PRRX2	8.66e-05	177	181	6	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	droplet-Lung-LUNG-30m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 DSG2 C11orf16 C6orf132 TYRO3 PKHD1	8.66e-05	177	181	6	092a345cb802f183322aa5542341ba2d96d4f06a
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL8A1 SHROOM3 SPEG TRPC3 LAMA2 CLSTN2	9.21e-05	179	181	6	f5bb4d3a27d56698473219970e764084096cc582
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA SPEG CCNK ATF7IP FYB1 PIGO	9.21e-05	179	181	6	30efe1f0394c0edb27b91890b5c4637b73cbc5ec
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	DOCK1 ACACB KDM6B ARHGEF11 ARHGEF10L USP5 PHF3 PLEKHG3 CBX7 IL17RA CPEB1	4.61e-07	194	181	11	1217_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	KCTD13 EXPH5 CLSTN2 PDE12 NFATC1 PHF3 RAB11FIP5 HAAO ULK1 RERE	4.59e-06	199	181	10	2341_UP
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1	3.33e-10	29	176	7	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 CLSTN2	5.34e-08	87	176	8	EFO_0004340, EFO_0004765
Disease	neuroticism measurement, cognitive function measurement	ASXL1 PCDHA9 CTTNBP2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 BRINP1 LRP8 SCAP TENM3 RAB11FIP5 RERE CPEB1	3.24e-07	566	176	16	EFO_0007660, EFO_0008354
Disease	neutrophil count, basophil count	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 ABCA7 RERE DNMT1	1.05e-06	224	176	10	EFO_0004833, EFO_0005090
Disease	Intellectual Disability	ZC3H14 TCF20 TRIO ACOT9 TBC1D7 APC2 GON4L KDM6B DLL1 SHANK3 FUCA1 GNAS	1.69e-05	447	176	12	C3714756
Disease	Phelan-McDermid syndrome (implicated_via_orthology)	TCF20 SHANK3	3.54e-05	2	176	2	DOID:0080354 (implicated_via_orthology)
Disease	Morphological abnormality of the central nervous system	APC2 DLL1	3.54e-05	2	176	2	C4021765
Disease	depressive symptom measurement	CTTNBP2 SGIP1 TCF20 PCDHA6 PCDHA3 PCDHA1 BRINP1 BTN1A1 C6orf15 PKHD1 RERE	5.43e-05	426	176	11	EFO_0007006
Disease	small intestine adenocarcinoma (is_implicated_in)	MAP2K1 MAP2K2	1.06e-04	3	176	2	DOID:4906 (is_implicated_in)
Disease	lateral occipital cortex volume measurement	NHLRC1 BRINP1 RAB44	1.33e-04	17	176	3	EFO_0010311
Disease	post-traumatic stress disorder symptom measurement	CTTNBP2 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.34e-04	82	176	5	EFO_0008535
Disease	Tourette syndrome, schizophrenia	TCF20 PHF3 RERE	1.59e-04	18	176	3	EFO_0004895, MONDO_0005090
Disease	Abnormality of refraction	PCDHA9 LRRC38 ZBTB4 LAMA2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 DCTN1 NFATC1 RERE	2.14e-04	673	176	13	HP_0000539
Disease	neutrophil count	PCDHA9 SGIP1 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 NHLRC2 KDM6B ABCA7 ANKRD13A PRCC TNFSF13B ANKRD11 CBX7 IL17RA RERE CCDC63 DNMT1	2.33e-04	1382	176	20	EFO_0004833
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	3.50e-04	5	176	2	C0152101
Disease	vital capacity	COL8A1 HIC1 SHROOM3 PCDHA9 TCF20 LINC02875 ZBTB4 WDR70 LAMA2 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA3 PCDHA1 NCOR2 ZNF341 ASPSCR1	4.50e-04	1236	176	18	EFO_0004312
Disease	pulse pressure measurement	COL8A1 HIC1 SHROOM3 PCDHA9 SGIP1 PCDHA13 PCDHA11 PCDHA8 PCDHA6 TRIM65 PCDHA3 PCDHA1 KDM6B LPP ANKRD11 MAP2K2 FER1L5 MAP4K2 DNMT1	6.84e-04	1392	176	19	EFO_0005763
Disease	MiT family translocation renal cell carcinoma	PRCC ASPSCR1	7.28e-04	7	176	2	C4518356
Disease	mean arterial pressure	SGIP1 TCF20 LINC02875 NHLRC2 PKHD1 RAB11FIP5 DLST RERE GNAS DNMT1	8.73e-04	499	176	10	EFO_0006340
Disease	hyperuricemia	BAZ1B NFATC1 GNAS	9.98e-04	33	176	3	EFO_0009104
Disease	Colorectal Carcinoma	FLNC POLE APC2 BRINP1 CLSTN2 ARHGEF10L NFATC1 NPAP1 PKHD1 LGR6 GNAS PIGO	1.09e-03	702	176	12	C0009402
Disease	RASopathy (implicated_via_orthology)	MAP2K1 MAP2K2	1.24e-03	9	176	2	DOID:0080690 (implicated_via_orthology)
Disease	glioblastoma (implicated_via_orthology)	POLE CPEB1	1.24e-03	9	176	2	DOID:3068 (implicated_via_orthology)
Disease	waist-hip ratio, high density lipoprotein cholesterol measurement	NHLRC2 C6orf15	1.54e-03	10	176	2	EFO_0004343, EFO_0004612
Disease	valine measurement	MOK ACACB NFATC1	1.75e-03	40	176	3	EFO_0009792
Disease	Noonan Syndrome 1	MAP2K1 MAP2K2	1.88e-03	11	176	2	C4551602
Disease	Turner Syndrome, Male	MAP2K1 MAP2K2	1.88e-03	11	176	2	C0041409
Disease	Female Pseudo-Turner Syndrome	MAP2K1 MAP2K2	1.88e-03	11	176	2	C1527404
Disease	Pancreatic Ductal Adenocarcinoma	ACACB ACOT9	1.88e-03	11	176	2	C1335302
Disease	neuroimaging measurement	SECISBP2L DCHS2 SHROOM3 CTTNBP2 UBAP2 LAMA2 MBD6 ARHGEF11 LRP8 ARHGAP22 ZNF469 PKHD1 PDXDC2P DLST RERE	1.94e-03	1069	176	15	EFO_0004346
Disease	Congenital muscular dystrophy	LAMA2 POMGNT1	2.24e-03	12	176	2	cv:C0699743
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	CRLF2 ATF7IP	2.24e-03	12	176	2	C0023485
Disease	cystatin C measurement	SHROOM3 APMAP BAZ1B FOXA2 USP5 PKHD1 ANKRD11 GNAS	2.96e-03	402	176	8	EFO_0004617
Disease	lymphocyte count	IL31RA UBAP2 EXPH5 TBC1D7 RAP1GAP2 PCDHA6 NHLRC2 ARHGEF11 ZNF469 NFATC1 TNFSF13B LPP ANKRD11 CBX7 RERE MAP2K2 CCDC63 DNMT1	2.98e-03	1464	176	18	EFO_0004587
Disease	eosinophil count	ADAMTS4 ZBTB9 RAP1GAP2 PCDHA6 KDM6B CRLF2 NCOR2 ATF7IP C6orf15 LPP ANKRD11 DLST IL17RA FUCA1 RERE MAP2K2 FER1L5 CCDC63	3.53e-03	1488	176	18	EFO_0004842
Disease	C-X-C motif chemokine 10 measurement	SHROOM3 BMP2K BRINP1 TENM3	4.18e-03	109	176	4	EFO_0008056
Disease	muscular dystrophy (is_implicated_in)	LAMA2 POMGNT1	4.54e-03	17	176	2	DOID:9884 (is_implicated_in)
Disease	Graves disease, thyrotoxic periodic paralysis	DCHS2 C6orf15	4.54e-03	17	176	2	EFO_0004237, MONDO_0019201
Disease	body surface area	LINC02875 ZBTB4 ZBTB9 DIDO1 NCOR2 TNFSF13B PKHD1 ANKRD11 GNAS DNMT1	5.43e-03	643	176	10	EFO_0022196
Disease	basophil measurement	RAB44 ZNF469 RERE	5.56e-03	60	176	3	EFO_0803539
Disease	Noonan-Like Syndrome With Loose Anagen Hair	MAP2K1 MAP2K2	5.66e-03	19	176	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	MAP2K1 MAP2K2	5.66e-03	19	176	2	C1843181
Disease	Cardio-facio-cutaneous syndrome	MAP2K1 MAP2K2	5.66e-03	19	176	2	C1275081
Disease	unipolar depression, response to bupropion, mood disorder	BHLHE41 FYB1	5.66e-03	19	176	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	Costello syndrome (disorder)	MAP2K1 MAP2K2	5.66e-03	19	176	2	C0587248

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLPPAAPGKEDKAPV	UNC13A	376	Q9UPW8
LEAPKPSGLEPGPAA	KCTD13	16	Q8WZ19
AEVRLLKGPPPFEDP	EVI5L	701	Q96CN4
VSVSDIKPPAPELGP	ARHGEF10L	291	Q9HCE6
PKSEPAAEEGALVPP	ASPSCR1	511	Q9BZE9
IAPPPSLAEPLKELF	ANKRD11	2491	Q6UB99
AVPPLPSPSKEEEGL	DCTN1	206	Q14203
KPEPEVDALGSPPAL	CRYBG3	921	Q68DQ2
LAAAPGEKLPLFPEP	DNMT1	1316	P26358
LAPPVAPGKPQLDLF	BRINP1	706	O60477
TGKPIPDQLLKEPPF	HAAO	156	P46952
LPKLDSAPFDVIGPP	BTN1A1	21	Q13410
PPPEKAGAAAATLLP	BHLHE41	421	Q9C0J9
PLVKPLPGEEPLFTI	BAZ1B	11	Q9UIG0
PPSAFPKGLGSELEP	FAM220A	171	Q7Z4H9
APPVEPPASALELKV	CDRT15P3	76	P0DPF6
SPKPLIIGPEEDYDP	ARHGEF11	286	O15085
PPGFPVKLDIPVFPT	ANKRD13C	491	Q8N6S4
PPDRKPPLAAALGEA	CCNK	371	O75909
KGPAFVNPLIPESPE	ACOT9	211	Q9Y305
DPQPLSFKEPPLLLG	APMAP	66	Q9HDC9
PPPAAEDFKGIILTL	CCDC180	1366	Q9P1Z9
LDPPLVALDKDAPVP	CLSTN2	61	Q9H4D0
PVELDPFGAAPFPSK	BMP2K	1146	Q9NSY1
PAFPAGDSKPELPLT	PPP1R13B	536	Q96KQ4
EKAAPTPPALPGDLT	ASXL1	931	Q8IXJ9
DPKVLVEEAPPGLSP	ABCA7	791	Q8IZY2
PPPKLPSGVFSLEFQ	MAP2K1	321	Q02750
PIPPPDAKELEAIFG	MAP2K2	266	P36507
PGELPDKFIIPGSPA	PCDHA9	881	Q9Y5H5
PAFKVLIPLEDGPPP	RAB44	491	Q7Z6P3
PVKPLSAAPVEGSPD	RAB11FIP5	526	Q9BXF6
SFLFKAPLVPPGSPV	ISYNA1	461	Q9NPH2
AAFALDKPALGPGPP	PRRX2	6	Q99811
PGELPDKFIIPGSPA	PCDHA6	881	Q9UN73
TIKRAPFLGPLPTDP	MAP4K2	401	Q12851
PSKVHPAEPFTGELP	ACACB	966	O00763
KLPPDDFLGSPELEV	ANGPTL7	146	O43827
LEFPPGFPVKIEIPL	ANKRD13A	401	Q8IZ07
GAPPEDKVVPSFLPV	DSG2	661	Q14126
SGLPFPVPPREVIKA	NCOR2	1051	Q9Y618
GELPDKFIIPGSPAI	PCDHA11	881	Q9Y5I1
PGKPALPLSPEDLES	IL17RA	821	Q96F46
PKVFNFDPLAPVTPG	MBD6	71	Q96DN6
PGELPDKFIIPGSPA	PCDHA8	881	Q9Y5H6
PGELPDKFIIPGSPA	PCDHA3	881	Q9Y5H8
RPGDPVFSFPSLPKD	NEUROG1	211	Q92886
LKDPEKGPVPTFQPF	NELFE	96	P18615
GKSFEELPVSPEIPP	IL31RA	651	Q8NI17
PVPLPPVKFVVGAIA	LGR6	591	Q9HBX8
AKGLPLPLPFPLLEV	CRB2	1211	Q5IJ48
PLEPEPGAAQPKLAV	FOXK2	401	Q01167
PLPFQKLEEAAPPSD	HIC1	291	Q14526
EEPEPTPGLVLSKPA	FLYWCH1	226	Q4VC44
EAGVAPQPPLKEPFA	KDM6B	716	O15054
LPPSRPDDLIKPGLF	FBXO31	291	Q5XUX0
DFALPCPPGLKIPEE	PCSK7	641	Q16549
LLKPLFPSCPVPEEA	SLC7A5P1	156	Q8MH63
PGPEPAVFCEPVVKL	PDE12	111	Q6L8Q7
ELPGSDPVFKAVPVP	PDXDC2P	396	Q6P474
PFAVEGVLPPDPSKV	FLNC	1051	Q14315
DLEPKPLFPKPAFGQ	FYB1	186	O15117
PDKGLFISLPQLPPS	FUCA1	436	P04066
PGAPFIELLPVKEGT	GHDC	316	Q8N2G8
FPVPSKFPLGPAAAV	NFATC1	6	O95644
SFLGAATVEPPKPIP	HERVK_113	11	P63132
GNFPPPPPLDEEAFK	LPP	86	Q93052
PLFPEPTPKSAESIG	EXPH5	1641	Q8NEV8
FPKPGFVELSPVPID	LAMA2	2531	P24043
GLPSVPDPFPLDVRK	LRRC38	46	Q5VT99
KAGFPEHPVAPEPLS	MOK	301	Q9UQ07
ESEKFPPLFPEGPAR	POLE	691	Q07864
LIPSVPDPKSIFPGL	CRLF2	261	Q9HC73
SFLGAATVEPPKPIP	ERVK-7	11	P63135
SLLGAATVEPPKPIP	ERVK-6	11	Q9BXR3
PPLTPVPLKRAEFAG	POLA1	216	P09884
SFKPGPLPPNLDDLK	MYOCD	361	Q8IZQ8
DSLPPSPLLFPGKVT	NHLRC2	216	Q8NBF2
PLLLVTAEPPKPAGV	PLBD1	26	Q6P4A8
KIIIFPPIPDPGKIF	IL13RA1	371	P78552
LVQPSDLPKDPAGPF	DCHS2	206	Q6V1P9
FPPPLITAVAQPGIK	DCHS2	3276	Q6V1P9
PGELPDKFIIPGSPA	PCDHA1	881	Q9Y5I3
PGELPDKFIIPGSPA	PCDHA13	881	Q9Y5I0
LLPPDKEESAPAPGH	PLIN1	191	O60240
PPLPNGLKPEFALAL	PPP1R37	631	O75864
GLKPEFALALPPEPP	PPP1R37	636	O75864
AVKPTVAPPLAEPGA	DLST	201	P36957
DGPPAPVLPGDKALD	FCHSD1	641	Q86WN1
PVLPGDKALDFPGFL	FCHSD1	646	Q86WN1
PLKLSVPASDGFPPA	C6orf15	76	Q6UXA7
LSLPAKDTPPGVPEK	C6orf132	516	Q5T0Z8
SFEVPKPLFPVAGVP	GMPPA	21	Q96IJ6
KPEAASPFGPDLVPV	HSPBAP1	381	Q96EW2
ELPLGRPPSAPADKD	APC2	1466	O95996
DKPEAPLHLPVTFPG	ADAMTS4	426	O75173
EGALPTPGKAAPLPA	GRHL3	136	Q8TE85
PIKVIPPVLGADPFS	CCDC63	496	Q8NA47
TGADVADVPPPLPLK	DOCK1	1791	Q14185
ADVPPPLPLKGSVAD	DOCK1	1796	Q14185
AVAEKPPPGEKPSVF	LIG4	486	P49917
LPPKPSIDLTVAPAG	CTTNBP2	611	Q8WZ74
PELPPGPAVVDLTEK	DLL1	521	O00548
LAPPPTTKICDPGEL	CNTFR	326	P26992
LFLLLDGAGDPKPTP	LINC02875	126	Q86X59
VISKFQEVPLGPLPP	GLB1L	351	Q6UWU2
VFPKVEHSPGPPLAD	GON4L	1261	Q3T8J9
VDKGPLVPTLPFPLR	CBX7	126	O95931
AQDPVPSKLLPFEGP	DIDO1	1166	Q9BTC0
PSKLLPFEGPGLESP	DIDO1	1171	Q9BTC0
PKTTAEDGVPAPPLL	DIDO1	1346	Q9BTC0
ELTAPFPPVGAPVKF	COL8A1	621	P27658
FKSEGPNPERFLIPP	CYP11A1	111	P05108
PVSKLPAEPVSGDPA	ATF7IP	121	Q6VMQ6
APFLFSPGVLLPEPE	MAMSTR	56	Q6ZN01
KPPLSFLPLDPLGSD	CPEB1	141	Q9BZB8
GPSVFLFPPKPKDTL	IGHG2	116	P01859
ELPFPPGVPTLDNIK	ECM1	296	Q16610
PVELDPFGAAPFPSK	BMP2KL	396	Q5H9B9
AVPAADGLGLSPKPP	PRDM13	181	Q9H4Q3
KLPLPGTGPVEFTTP	SCAP	46	Q12770
ILASPKLGATPLPPE	SALL2	141	Q9Y467
KGPEPVPLEFIPAQG	NOC4L	486	Q9BVI4
PAILCLGKPEEFPVP	NHLRC1	341	Q6VVB1
PAPALKELFVLPGEP	LRP8	916	Q14114
SAPTKKPALPFGDLP	PAMR1	386	Q6UXH9
ELKGTPAAALSPPEP	FOXA2	321	Q9Y261
PLGPSKAFEPEGLVL	GAREM2	736	Q75VX8
LPSPPVFQKGPEFRE	RAP1GAP2	416	Q684P5
PEPKPGDLIEIFRPF	PLAAT3	6	P53816
FFSLPEKAEPPGVEP	PRCC	276	Q92733
DPFPEGPLLKLLPLD	SPATA5L1	6	Q9BVQ7
RKGLPPPLFSPEEDA	FER1L5	1616	A0AVI2
EFPPALKPPEDLVVL	NKRF	306	O15226
VKGDPPPISDAEFRP	PLEKHG3	796	A1L390
TEALPPARKEGDLPP	NDUFB9	151	Q9Y6M9
PIEFSPDPLPDNKVL	POMGNT1	286	Q8WZA1
DSPPIALDGPPIKVS	GNAS	326	Q5JWF2
PEVGEAPLKASLPEP	PRAM1	146	Q96QH2
AGGDPPLLKLTAPAV	PPP1R16A	501	Q96I34
LPSDFIPKAGALALP	SHROOM3	1956	Q8TF72
PFDTPPIGKQPSLVA	SECISBP2L	911	Q93073
ALGLPPPVSVFPKTE	PKHD1	3361	P08F94
GFEVKPPELDPLHPA	RERE	1326	Q9P2R6
SGKLPRSPSFPLEPD	TBC1D7	116	Q9P0N9
LPPPAKLPCLSVEGD	NPAP1	351	Q9NZP6
FPRGELESPKPLVTP	TGIF2	146	Q9GZN2
LPPGPEDPGKHLFEI	ARHGAP22	91	Q7Z5H3
PIPDLFPPGQITDLK	CLCA1	746	A8K7I4
LPPPPTFSLVQAGDK	CLCA2	296	Q9UQC9
PEPPLSLAPGKVEGE	CLCN1	936	P35523
LVEFEAPLVAGPKLP	C11orf16	116	Q9NQ32
SFLGAATVEPPKPIP	ERVK-25	11	P63136
FPGPEPLAFPVKELQ	PRR22	221	Q8IZ63
LDRPPTPLFIPAKTG	RSPH3	281	Q86UC2
VDPASAPGLPFPLLE	ZNF414	226	Q96IQ9
VPPPGLESFPSQAKL	UBAP2	451	Q5T6F2
AGLVPEAVPGKPPFA	ZNF341	781	Q9BYN7
EPKPFVLDTGTPIPA	SPEG	2871	Q15772
DGHTFLLEKPPVPPK	SHANK3	1401	Q9BYB0
PDDTTALAPLFGPPL	SGIP1	191	Q9BQI5
DSSDDELIGPPLPPK	WDR70	111	Q9NW82
VPALPSKLPTFGAPE	TRIM25	396	Q14258
APGAFPTPLLLEVKA	TRIM75	396	A6NK02
SFLGVATIEPPKPIP	ERVK-8	11	P63133
VLPDEKGAGALPFLP	ZBTB4	951	Q9P1Z0
KIPHPLVPFDGPGLE	PHF3	1321	Q92576
SFLGAATVEPPKPIP	ERVK-11	11	Q9UQG0
IPGFPVPKFDLTEPS	TENM3	2421	Q9P273
AGLIIPPAPTKPDFD	SNX5	86	Q9Y5X3
FPDSKNVPPVGILAP	TCF20	1491	Q9UGU0
PFLEDPSQLPPKDGT	TIMM17B	146	O60830
KPVLPLPTQPSFEEG	ZNF469	2856	Q96JG9
KLPEGESAPLELPAP	ZBTB9	261	Q96C00
GALPPPSPKLKDEDF	ZNF598	431	Q86UK7
PPEGFIPDLSKPLLD	FTSJ1	201	Q9UET6
ALKAAGPASPPEEDP	ZNF512B	401	Q96KM6
PREPPVSLPFLGKLS	PIGO	91	Q8TEQ8
LGKLPSGFDLIPPAE	TASOR2	236	Q5VWN6
SFLGAATVEPPKPIP	ERVK-19	11	Q9WJR5
KAEPFIVGALQVPPP	TBCCD1	11	Q9NVR7
SPLPGEEEKPLALSP	ZNF524	11	Q96C55
PAVTAGLKIFEPPAP	TNFSF13B	106	Q9Y275
APAKPVDLAPVEAPG	TRIM65	296	Q6PJ69
PKFIVTLDGVPSPPG	ZC3H14	516	Q6PJT7
DIAPPLVTPDEPKGS	USP5	616	P45974
GDLVAEAPSAKPPPD	ULK1	366	O75385
IPEAPLEGPLGPYKL	TYRO3	346	Q06418
FGKPDPLPAVLPAPV	nan	176	A6NL46
FPSPFDPLTLPEKPL	ZMYM3	6	Q14202
DPLTLPEKPLAGDLP	ZMYM3	11	Q14202
LSSAVPSLGKEPFPP	TRIO	2461	O75962
DDGKTLPPPFSLVPS	TRPC3	686	Q13507
GKASEPLLSPPPFGE	KMT2D	2266	O14686
PLLSPPPFGESRKAL	KMT2D	2271	O14686
PGLVLESPSKPLAPA	NACA	1821	E9PAV3
LPEELPGVKPFTRGP	MMUT	81	P22033
LGAPSPGDKPIFVPL	NAPSA	56	O96009